Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Richard Van
Observed name:
Van, Richard
Institutions:
Koch Institute for Integrative Cancer Research At MIT,
Massachusetts Institute of Technology
Observed institutions:
University of Nevada, Las Vegas,
University of California, San Francisco,
UCSF Helen Diller Family Comprehensive Cancer Center,
Koch Institute for Integrative Cancer Research At MIT,
Massachusetts Institute of Technology,
University of California, Davis
show all 6
ORCID:
0000-0002-0870-4788
Observed ORCID:
0000-0002-0870-4788
OpenAlex ID:
A5055517021
Expansion of tumor-reactive CD8 + T cell clonotypes occurs in the spleen in response to immune checkpoint blockade
2024
·
Duncan M. Morgan
, Brendan L. Horton
, et al.
·
Science Immunology
·
66
The RAS GTPase RIT1 compromises mitotic fidelity through spindle assembly checkpoint suppression
2021
·
Antonio Cuevas-Navarro
, Richard Van
, et al.
·
Current Biology
·
35
PDF
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy
2023
·
Antonio Cuevas-Navarro
, Morgan Wagner
, et al.
·
Science Advances
·
34
PDF
The molecular functions of RIT1 and its contribution to human disease
2020
·
Richard Van
, Antonio Cuevas-Navarro
, et al.
·
Biochemical Journal
·
26
Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion
2025
·
Kristen A. Rodrigues
, Yiming J. Zhang
, et al.
·
Science Translational Medicine
·
24
PDF
Genetic deletion of Urocortin 3 does not prevent functional maturation of beta cells
2020
·
Jessica L Huang
, Sharon Lee
, et al.
·
Journal of Endocrinology
·
19
PDF
The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery
2022
·
Maria I. Kontaridis
, Amy E. Roberts
, et al.
·
American Journal of Medical Genetics Part A
·
16
PDF
Radiation therapy synergizes with mRNA vaccination to overcome microglia-mediated suppression of dendritic cell migration and T cell priming in glioblastoma
2026
·
Amy J. Wisdom
, Zachary J. Rogers
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
711 Vaccination route programs qualitatively distinct dendritic cell activation states that shape anti-tumor CD8 T cell fate in ICB-resistant lung cancer
2026
·
Richard Van
, Sebnem Gul
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Abstract A049: CD8+ T cell decline from regression to recurrence in ovarian cancer is linked to expansion of suppressive macrophages
2026
·
Grace Wolczanski
, Emma Schuler
, et al.
·
Cancer Immunology Research
530 Antigen-dependent differentiation and expansion of tumor-infiltrating CD8+ T cell clonotypes occurs in the spleen in response to immune checkpoint blockade
2024
·
Vidit Bhandarkar
, Brendan Horton
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
20
Citation count:
221
H-index:
7
I10-index:
7
Year
Topic
Type